Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
64.12
-0.06 (-0.09%)
Nov 21, 2024, 1:10 PM EST - Market open

Utah Medical Products Revenue

Utah Medical Products had revenue of $10.01M in the quarter ending September 30, 2024, a decrease of -19.99%. This brings the company's revenue in the last twelve months to $44.08M, down -14.35% year-over-year. In the year 2023, Utah Medical Products had annual revenue of $50.22M, down -3.93%.

Revenue (ttm)
$44.08M
Revenue Growth
-14.35%
P/S Ratio
5.19
Revenue / Employee
$231,989
Employees
190
Market Cap
217.47M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202350.22M-2.06M-3.93%
Dec 31, 202252.28M3.23M6.58%
Dec 31, 202149.05M6.88M16.30%
Dec 31, 202042.18M-4.73M-10.08%
Dec 31, 201946.90M4.91M11.68%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
High Tide 370.02M
Inogen 331.52M
biote 193.06M
Sutro Biopharma 160.96M
Genfit 86.23M
SOPHiA GENETICS 64.49M
Zentalis Pharmaceuticals 40.56M
TScan Therapeutics 9.36M
Revenue Rankings